Newmark Group, a leading commercial real estate advisor, announced its financial results for Q3 2026 and declared a quarterly dividend. The company generated over $3.7 billion in revenue for the 12 months ending September 30, 2026, operating from around 200 offices globally. A conference call to discuss these results and the company's financial outlook is scheduled for today at 10:00 a.m. ET. Forward-looking statements about future performance were also highlighted, with risks noted in SEC filings.
Newmark's Q3 2026 financial results provide context for readers interested in real estate. For readers following the real estate sector, here is Pluang's market snapshot as of Oct 29, 2026 19:13 WIB: Among 47 US real estate stocks priced on Pluang, 42 advanced while 5 declined. Notably, CBRE Group Inc Class A traded at USD 125.30 with a 1.29% gain and a typical hold time of 8 days, contrasting with Realty Income Corp at USD 56.99, which saw a 1.35% rise but had a much longer typical hold time of 129 days. CareTrust REIT Inc was priced at USD 35.93 with a 1.35% increase and a typical hold time of 14 days.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
